Development of A Hospital Formulary In A Tertiary Care Hospital
Journal Title: American Journal of PharmTech Research - Year 2019, Vol 9, Issue 0
Abstract
One of the important fundamental human rights is access to health care. Various governments have shown international agreements about this right. Disease management and prevention is mainly through drugs. Complete information about the drugs is given in World Health Organization (WHO) formularies. Aim of the study was to develop a hospital formulary in a tertiary care hospital. Drug list comprising of 450 drugs was collected from hospital pharmacy. After scrutinizing the list for unutilized and banned drugs, a total of 423 drugs were selected to prepare monographs for hospital formulary. The hospital formulary book was distributed to the doctors, nursing staff and pharmacy to avoid medication administrative errors and also to provide ease of reference. The formulary was also designed in a way to help the patients receive drugs economically by including the high quality drugs of affordable brands. Results showed that fixed dose combinations accounts for highest percentage of drugs in Varma hospital formulary i.e., 22.22% (n=94) whereas it is only 8.19% (n=28) in National formulary of India whereas blood products accounts least i.e., 1.89% (n=8) in Varma hospital formulary and 1.46% (n=5) in National formulary of India. Development of hospital formulary system helps in reducing the number of brands for the same drug, selecting the drugs at affordable cost with superior quality. On a whole, the formulary helps in providing quality treatment to the patient in a standardized way.
Authors and Affiliations
Tirumala Konduru
Aromatic C-acylation of Phenols by using Acid and Acid Anhydride in Presence of Lewis Acid Catalyst
Ring acylations of aromatic substances are very difficult to achieve to a great extent. Nencki reaction has attempted on mono to poly hydroxy and substituted phenols have good results. Reactions are using solely acetic a...
Gold Nano Particles of Cancer Treatment: A Review
Gold nanoparticles are emerging as promising agents for cancer therapy and are being investigated as drug carriers, photothermal agents, contrast agents and radiosensitise. Cancer is the disease caused by an uncontrolled...
Microparticle as Suitable Drug Carriers For Colon Targeting – A Recent Review
In the recent year colonic drug delivery has gained importance for delivery of drug for the treatment of local diseases associated with colon and systemic delivery of therapeutic peptides and proteins. Treatment could be...
Oral Lichen Planus: Theory and Management
Oral Lichen Planus (OLP) is a chronic inflammatory disease that affects the mucous and cutaneous tissue inside our mouth. It is a T cell mediated autoimmune disease. The two major types of OLP are Reticular OLP and Erosi...
Analytical Method Development and Validation for Enrofloxacin in Bulk and Formulation by RP-HPLC Method
Enrofloxacin (EFX) is a third generation Fluoroquinolone with a broad spectrum antibacterial activity. Enrofloxacin hydrochloride is 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1, 4-dihydroquinoline-3-carboxyl...